相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases
Joseph Meserve et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy
Linda A. Feagins et al.
INFLAMMATORY BOWEL DISEASES (2020)
Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer
Jaehyun Kim et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Hamzah Abu-Sbeih et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study
Ola Olen et al.
LANCET (2020)
Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study
Akbar K. Waljee et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017
Asa H. Everhov et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease
Daniele Piovani et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Repeated Occurrences of Basal Cell Cancer in Patients With Inflammatory Bowel Disease Treated With Immunosuppressive Medications
Nabeel Khan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy
Martina Taborelli et al.
PLOS ONE (2020)
Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis
Shilpa Grover et al.
JCO ONCOLOGY PRACTICE (2020)
Surgical Management of Dysplasia and Cancer in Inflammatory Bowel Disease
James Ansell et al.
SURGICAL CLINICS OF NORTH AMERICA (2019)
Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis
Nienke Z. Borren et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Risk of skin cancers in thiopurines-treated and thiopurines-untreated patients with inflammatory bowel disease: A systematic review and meta-analysis
Shao-Zhuo Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Short-term Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel Disease
W. Mohammed et al.
CLINICAL ONCOLOGY (2018)
Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?
Yuehong Chen et al.
CYTOKINE (2018)
Assessment of thyroid cancer risk in more than 334,000 patients with inflammatory bowel disease: a case-control study and a meta-analysis
Lihong Cao
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
A. M. Menzies et al.
ANNALS OF ONCOLOGY (2017)
Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study
Jacqueline So et al.
INFLAMMATORY BOWEL DISEASES (2017)
Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
A. Bourrier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Risk of Second Primary Malignancies Among Cancer Survivors in the United States, 1992 Through 2008
Nicholas Donin et al.
CANCER (2016)
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents
Jordan Axelrad et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis
Edward Shelton et al.
GASTROENTEROLOGY (2016)
Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort
Tim R. A. van den Heuvel et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease
J. Claire Wilson et al.
JOURNAL OF GASTROENTEROLOGY (2016)
The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis
Lucia Silva-Fernandez et al.
RHEUMATOLOGY (2016)
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
Douglas B. Johnson et al.
JAMA ONCOLOGY (2016)
Interaction of Salicylates and the Other Nonsteroidal Anti-Inflammatory Agents With Breast Cancer Endocrine Treatment Systematic Review
Eugenia Ch Yiannakopoulou
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2015)
Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques
Colin T. Murphy et al.
PRACTICAL RADIATION ONCOLOGY (2015)
Association Between Thiopurine Use and Nonmelanoma Skin Cancers in Patients With Inflammatory Bowel Disease: A Meta-Analysis
Jonathan Ariyaratnam et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Melanoma associated with tumour necrosis factor-α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project
B. Nardone et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer
Laurent Beaugerie et al.
GUT (2014)
Inflammatory bowel disease and risk of cervical cancer: a meta-analysis
Pingping Wang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease
Nynne Nyboe Andersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease
Bjorn Pasternak et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
Parakkal Deepak et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-analysis of Population-based Cohort Studies
Maurice W. M. D. Lutgens et al.
INFLAMMATORY BOWEL DISEASES (2013)
Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer
Carmine Stolfi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
Pauline Raaschou et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
GASTROENTEROLOGY (2012)
Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives
Carmine Stolfi et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs
X. Li et al.
ONCOGENE (2012)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Tobacco smoking and cancer: a brief review of recent epidemiological evidence
AJ Sasco et al.
LUNG CANCER (2004)
分享论文
